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Abstract: Puropse. To investigate the engagement of community pharmacists (CPs) with pharmacy
research and identify barriers preventing them from doing so. In addition, to determine the training
and research tools available to support CPs to take part in research. Methods. A questionnaire was
designed and distributed to a sample of community pharmacies (n = 323) within five local authorities
in England, and to a random sample of community pharmacies (n = 329) within Greater London in
two stages. Descriptive statistics were used to analyse the data using Microsoft Excel. Following
questionnaire completion, CPs were invited to take part in face-to-face and telephone interviews
to further explore their views on research. Interviews were transcribed and analysed using coding
and thematic analysis. Results. A total of 104 questionnaires were completed out of 652 distributed.
Over half (56.7%) of respondents considered research to be important to their practice. Approximately
88% of respondents had completed some form of mandatory research in the past two years, while
only 29% were involved in non-mandatory research. Over two-thirds (67.9%) wanted to engage with
research in the future, with 22.2% of these being most interested in recruiting patients for research.
Barriers to research included lack of time (90%) and lack of remuneration (60%). 20 community
pharmacists were interviewed. Three themes were identified: 1. Interest in taking part in research;
2. Awareness, support and knowledge; 3. Resources as barriers. Conclusion. CPs recognise the
importance of research in their current practice, however, the biggest barrier they face is time. Further
training may be useful to ensure CPs are adequately prepared to undertake research activities.
Keywords: community pharmacy; pharmacy research; pharmacy services; evidence-base
1. Introduction
In the UK, community pharmacists (CPs) are relied upon to provide evidence-based and
cost-effective support to the public and other healthcare professionals [1].
Pharmacists deliver their role as part of a National Health Service (NHS) contract. As the NHS
becomes more cost conscious, it needs reassurance that pharmacy initiatives are value for money and
backed by robust research [2,3].
The Pharmacy in England report states, “ . . . for [a] pharmacy to be recognised as a key and
essential element in the delivery of clinical services, a sound evidence base that demonstrates how
pharmacy delivers effective, high quality and value for money services is needed” [4]. The report
acknowledged the value of practice research and found a number of studies, mainly overseas, that
strongly support the services run in community pharmacies [5]. It concluded that there is a demand
for research to be done in the UK that can directly correlate with pharmacy practice.
Clinical Commissioning Groups (CCGs) and Local Authorities (LAs) are NHS bodies that are
responsible for commissioning health services in the areas in which they serve [6]. They base their
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decisions on three factors: resources, value, and evidence [7] to show efficiency, quality, and performance.
Pharmacy practice research (PPR) is thus essential in showcasing an evidence base to protect, justify,
and develop pharmacy roles and services [8]. It tries to “understand pharmacy ... to ensure that
pharmacists’ knowledge and skills are used to best effect in solving the problems of the health
service” [9,10]. PPR has been a facilitator for services implemented through pharmacy, for example,
smoking cessation service, [5] repeat dispensing service [11], and advanced pharmacy services:
medicine use reviews (MURs—supporting patients on multiple medicines to improve adherence)
and new medicine service (NMS—supporting patients on newly prescribed medicines to improve
adherence) [12,13].
For pharmacists interested in research, the Royal Pharmaceutical Society (RPS) introduced a
Research Resource Hub in July 2016. The aims of the hub are to inspire pharmacists to become
involved in research and to provide support to those keen on developing this aspect of their career [14].
Charities such as Pharmacy Research UK [15] aim to build pharmacy research capacity and capability
through grants, training bursaries, and post-graduate research funding.
Apart from a short research report, [16] a recent systematic review [17] highlighted that the
last published study of UK-based community pharmacists’ perceptions of research was in 2000 [18].
Two of the studies that explored pharmacists’ attitudes towards research, in the UK in 2000 [18] and
Australia in 2009 [19], suggested that pharmacists do realise that research is valuable to the profession.
Interestingly, 33% of pharmacists in the Peterson et al. [19] study and 43.2% of pharmacists in the
Rosenbloom et al. [18] study had previously done some research. The main barrier to research in the
latter study was the fact that no payment was received for the work done, while in the former study,
the main barriers were lack of time and lack of notification about research priorities.
Recent threats of cuts to pharmacy funding have hastened the need to encourage more CPs to
become involved in research, to showcase how they can deliver positive and lasting health outcomes
for a new NHS. This study aimed to determine the level of CP engagement with research in England,
to explore the resources and topics that can act as facilitators for their engagement, and the barriers
that prevent them from participating in research.
2. Materials and Methods
The study employed a mixed method approach in the form of a survey followed by interviews.
A questionnaire was designed consisting of 20 questions in five sections: Community pharmacists
and the importance of research; Past and current engagement in research; Future engagement in
research; Facilitators and barriers to research; and Demographics (no identifiable data required).
A brief definition of research and its different types (Table 1) was provided as part of the questionnaire.
These definitions were obtained from the Royal Pharmaceutical Society (RPS) research and evaluation
hub [14].
There was also an invitation to take part in an interview to further explore attitudes on practice
research. An interview schedule was devised to conduct short semi-structured interviews (Table 2).
The delegated ethical approval team operating under the Kingston University Science, Engineering
and Computing faculty ethics committee granted ethical approval for the survey on 14 January 2013 and
the interview schedule on 27 March 2013 (1213/045).
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Table 1. Types of research conducted in community pharmacy.
Mandatory Research
Community Pharmacy Patient Questionnaire Obtaining patient perceptions of the service provided by acommunity pharmacy
Clinical audit A tool to compare how a pharmacy service is delivered based onpre-agreed standards
Non-mandatory research
Service evaluation Reviewing whether a service is meeting the needs of the patients
Clinical trials A way to find out how effective an intervention is
Applied health research Research that can be applied to a real problem
Research Methods and When They Are Used [14]
Survey (Quantitative) Efficient way of obtaining information from a large numberof respondents
Interview (Qualitative) To gain an understanding of underlying reasons andmotivations—participants can give in-depth reasons and explanations
Focus group (Qualitative) Similar to interview but in addition, allows discussion and forming ofopinions in a natural interactive process
Table 2. Interview schedule used to interview community pharmacists (CPs) about their opinions of
CP involvement in pharmacy research.
Interview Schedule
Are you aware of the current push for research and the research ready tools?
Are you a member of the RPS?
Which sources, sites and avenues could be used to push research and be accessed by pharmacists?
What are some of the barriers to research?
Have you participated in any research yourself?
What research projects would you be interested in doing in the future?
What sort of training have you received to help you in taking part in research?
What sort of training tools do you think would help pharmacists engage in research?
What are some of the facilitators for research?
What level would you like to engage in research?
The study was carried out in two stages over two years (2013 and 2014). The first stage addressed
pharmacist perceptions across England. Stratified sampling was used to divide England into 5 major
regions: North of England, East of England, London (South of England), Welsh Borders and West
Country (South West England), and the Midlands. Each region was then divided into 4 areas: north,
south, east, and west. Random sampling was used to select a county and a local authority within each
of the 5 areas selected. The local authorities selected for this study were: Bedfordshire, Cornwall and
Isles of Scilly, Richmond and Twickenham, and Wakefield and Warwickshire. The total number of
pharmacies was identified in each local authority. A sample size for each local authority was calculated
using a Raosoft sample size calculator [20], providing a confidence level of 95% and a margin of error
of 5% (Table 3). The total sample size calculated for all five local authorities was 323.
Table 3. Sample calculated and determined using Raosoft sample size calculator.
Local Authorities
Posted Hand Delivered
Bedfordshire Cornwall andIsles of Scilly Wakefield Warwichshire
Richmond and
Twickenham
Total number of pharmacies 70 96 73 104 45
Recommended sample size 60 77 62 83 41
Responses recieved 15 26 20 19 24
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The second stage of the study addressed perceptions of pharmacists working in community
pharmacies in Greater London (n = 2250) [21]. A sample size of 329 was calculated using a Raosoft
sample size calculator [20], providing a confidence level of 95% with a margin of error of 5%. In both
stages of the study, an assumption was made that there would be one pharmacist working in each
pharmacy. Pharmacies within the research area were assigned a number; this was then randomised
using an online randomisation tool.
Questionnaires were distributed by post, with stamped addressed envelopes included to
encourage their return. To enhance the response rate, pharmacists in the local area (Richmond
and Twickenham) were also approached in person to complete the survey. In addition, an online
version of the questionnaire was created in Google Drive and sent via email to pharmacies who
had not responded within 2 weeks. Their email addresses were obtained from the NHS Choices
website [21]. All CPs were given a participant information sheet and were given two weeks to return
their questionnaire. Pharmacists who had not responded by the deadline were telephoned to check
they had received the information and asked if they were still interested in participating in the study.
Completion of the questionnaire was accepted as informed consent.
All responses were entered into a Microsoft Excel spreadsheet and analysed using descriptive
statistics.
Following completion of the questionnaire, CPs who indicated that they were willing to participate
in the second phase of the study were invited for interview. Having established pharmacists’
interpretations of research and their understanding of the different types of research through the
questionnaire, the aim of the interview was to explore pharmacists’ involvement in research and the
barriers they faced. The interview schedule was piloted by 5 community pharmacists. No changes
were recommended. Interviews were to be conducted until a saturation of themes had been achieved.
Greater London was chosen due to its convenience of access to conduct interviews.
The interviews were conducted by the female authors AO and DB, as part of their integrated
Masters qualification. Both researchers received interview skills training at the university. In advance
of the interview, the interviewee was given a participant information letter and consent form to
sign. Interviews were carried out in either the private consultation room at the place of work of
the CP, with only the interviewer and interviewee present, or over the telephone. These took place
at a time, indicated by the CP, which would be least likely to have interruptions. Each interview
took approximately 20 min to complete. These were digitally audio-recorded with the permission of
the interviewee. Written transcripts of each recording were prepared and participants were asked to
comment on their accuracy. The transcripts were analysed using coding and thematic analysis in NVivo
qualitative data analysis Software, version 11 (QSR International Pty Ltd., Melbourne, Australia). This
was done using inductive (from data) and deductive (from literature) approaches. The transcripts were
read and re-read several times, and coded manually and independently by two researchers. Thereafter,
the codes were checked by a third researcher and discussed by all researchers to ensure consistency of
findings. Results are presented as themes with quotes from interviews used to support these.
3. Results
A total of 104 questionnaires were collected out of the 652 posted and hand delivered over both
stages of the research, giving a response rate of 16.0%. The breakdown of how many responses were
received from each local authority is shown in Table 3. The sample demographics (n = 104) are shown
in Table 4. In addition, Table 5 highlights community pharmacist perceptions towards practice research.
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Table 4. Sample characteristics (n = 104).
Characteristic N (%)
Gender
Female 55 (53%)
Male 49 (47%)
Type of employer
Multiple pharmacy (>10) 67 (64%)
Small multiple pharmacy (2–10) 8 (8%)
Independent pharmacy 29 (28%)
Average Years
Experience as a pharmacist 13
3.1. Community Pharmacists (CPs) and the Importance of Research
Answered using a 5-point Likert scale, over half (56.7%) of the respondents considered research
to be important to their current practice and 45.3% agreed that research should be a priority. Over a
quarter (26.4%) of pharmacists didn’t perceive research to be part of their role and just over one tenth
(13.5%) considered research to be unimportant.
Almost two-thirds (60%) felt that they had the necessary skills to do research, with 38% stating
that they would be prepared to make time for research during their working hours. The majority
(86.8%) agreed that research is vital to the development of new pharmacy services, but only under a
third (30.2%) felt that there were plenty of opportunities for community pharmacists to take part in
research (Table 5).
Table 5. General perceptions of community pharmacists (n = 104) towards practice research.
Statements Strongly Agree Agree Neither Agreenor Disagree Disagree
Strongly
Disagree
% % % % %
There is an abundance of opportunities for
community pharmacists to take part in research 3.8 26.4 24.5 34 11.3
Community pharmacists have the necessary skills to
do research 17 43 20.8 17 1.9
I would be prepared to make time for research
during my working hours 5.7 32.1 20.8 26.4 15.1
Research is fundamental to the future of the
pharmacy profession 26.4 49.1 17 7.5 0
My daily activities prevent me from engaging
in research 24.5 39.6 20.8 13.2 1.9
I don’t perceive research as part of my role as a
community pharmacist 7.5 18.9 28.3 35.8 9.4
Remuneration is an incentive for me to participate
in research 37.7 34 17 7.5 3.8
I have the storage and electronic capacity to hold
research data in the pharmacy 15.1 22.6 22.6 22.6 17
Research is vital to the development of new
pharmacy services 24.5 62.3 7.5 5.7 0
I would engage in research if I had fully capable
pharmacy staff for support in the workplace 26.4 54.7 11.3 5.7 1.9
The way I practice has been influenced by research 17 24.5 37.7 17 3.8
Research should be a high priority for
community pharmacists 13.2 32.1 37.7 13.2 3.8
It is important that community pharmacists are
kept informed of research relevant to the practice
of pharmacy
30.2 54.7 13.2 1.9 0
If I knew my competitors were involved in research,
I would want to get involved too 7.5 37.7 34 13.2 7.5
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3.2. Past and Current Engagement in Research
Approximately 88% of CPs surveyed had completed an audit within the past two years and nearly
two-thirds (62.7%) had taken part in a service evaluation in the same period.
In relation to non-mandatory research, i.e., research that is not part of the NHS pharmacy contract,
33.3% of CPs had not participated in any within the past two years. Meanwhile, 29% were involved in
research which included clinical trials, applied health research, and clinical research.
3.3. Future Engagement in Research
Over two-thirds (67.9%) of CPs specified that they would like to engage in research in the
future. There were differences depending on types of employer. Whereas 61% of CPs working in a
multiple chain pharmacy wanted to engage in research, only 38.9% of those in independent pharmacies
were interested.
Over three quarters (77.8%) in the 20–29 age categories wanted to engage in research, compared
to 35.3% of 50–59 year-olds who wanted to engage in research.
For CPs interested in research, 22.2% were interested in recruiting patients for research with the
same percentage interested in completing audits and service evaluations. Research topics that CPs
wanted to engage with included diabetes (41.2%), medicines management (29.4%), and cardiovascular
disease (17.6%).
3.4. Facilitators and Barriers to Research Participation by CPs
Barriers to completing research included lack of time (90%), lack of remuneration (60%),
and insufficient training (45%).
Over two-thirds (69%) thought training tools would help facilitate research, whilst 52% thought
protected time for research activities would be beneficial. 54.9% of CPs wanted to learn more about
data collection and research tool design.
3.5. Interviews
Of the 104 pharmacists who completed the survey, 12 were interviewed over the telephone and 8
were interviewed at their place of work. The sample demographics (n = 20) are shown in Table 6.
Table 6. Demographics of pharmacists interviewed (n = 20) about their views on research.
Telephone Interviews
(n = 12)
Face-To-Face Interviews
(n = 8)
Gender
Male 6 3
Female 6 5
Age
20–29 4 2
30–39 5 3
40–49 2 2
50–59 1 1
Type of community
pharmacy
Independent 3 5
Small multiple 1 2
Large multiple 8 1
Interviews were carried out until data saturation was reached [22]. The stopping criterion for data
saturation, which is the number of interviews conducted without any new information after which
recruitment was stopped, was six.
Three key themes emerged from the analysis:
• Interest in taking part in research
• Awareness, support, and knowledge
• Resources as barriers
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3.5.1. Interest in Taking Part in Research
Pharmacists reported being interested in research activities. They would like to be involved in
research that was related to their day-to-day practice, particularly in relation to health promotion and
patient care. This was typified in the following examples:
“Looking at community pharmacy research . . . it would have to be based around factors
that improve patient care . . . health promotion . . . public health issues.” (#1)
“I am interested in research . . . it’s only through research that you are more current and
can give better advice . . . ” (#6)
3.5.2. Awareness, Support, and Knowledge
The pharmacists felt they lacked the necessary knowledge to take part in research. They were
also unaware of the areas of interest for community pharmacy research. They felt that organisations
such as the Primary Care Research Network (PCRN) and Local Pharmaceutical Committees (LPCs)
could do more to promote engagement in research and to encourage pharmacy contractors to work
together on research priorities:
“ . . . I don’t see a lot of that coming from our LPC. And they’ve never asked to see what
audits and things that we’re doing and saying, ‘Let’s collaborate and get all that information
together’ which would be a nice situation but there’s a lot of politics involved in that as
well, so . . . ” (#10)
Pharmacists reported that if management were supportive of research, then they would be more
likely to become involved:
“Big companies . . . need to put research on their agenda . . . in that way it will filter down
to the pharmacist.” (#12)
Some felt that had they learned more about research skills at university they would be more
receptive to taking part in it:
“ . . . if these things were started off earlier on in our career, you would tend to carry on
with it. I think within university if they changed the degree slightly, maybe have more
input with drug companies and research then maybe we could be more inclined to get
involved.” (#3)
3.5.3. Resources as Barriers
Finding time for research was of concern to many. Some felt that adding research to their workload
would over-burden them when they are already busy:
“I mean . . . doing evidence-based research is something that everybody would like to do
. . . the reality is . . . do you have enough time in your day?” (#7)
The prospect of remuneration for the time needed to take part in research was appealing to
some pharmacists:
“If it is incentivized . . . I will be more likely to be involved in research.” (#4)
Suggestions were made that pharmacy support staff could help the pharmacist with
research activities:
“My staff, if I tell them what to do . . . yes they have the capabilities to help.” (#19)
In addition, lack of appropriate infrastructure was identified as a barrier to research:
“One of the hardest things is when we receive information it’s quite difficult to fit it in with
the IT because it quite often comes in standalone project. If it had been computer based it
would have been a lot easier and obviously time is a big factor” (#16)
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4. Discussion
This study has highlighted that community pharmacists are interested in taking part in research
activities, believing that research improves patient care. In fact, the findings from the questionnaires
showed that more than half of the CPs surveyed considered research to be important to their current
practice. These views were similar to those held by CPs in other studies [17–19,23]. Some CPs even
went so far as to express concern that pharmacy services would be cut if it could not be proved
by research to be effective. This is because the model of service commissioning is dependent on
performance [1]. The performance of these services can only be determined by pharmacy research, so
if CPs do not participate, then there will be no evidence to support the efficiency of services provided.
Nevertheless, most research in community pharmacy appears to be the completion of mandatory
tasks such as audits and service evaluations with 88.2% of respondents having completed one or
the other within the last two years. The numbers dropped sharply when it came to non-mandatory
research. These findings indicate that CPs are prioritising mandatory research as it is part of their
contractual framework with some suggesting that involvement in non-mandatory research is for
academics. This is supported by another study, [9] which states that CPs still consider research to
be reserved for academic institutions. Other reasons given for lack of involvement included lack of
time, no remuneration, the workload, lack of support from management, and the fact that they were
not approached. Similar findings were noted by Elkaseem et al. [23] when evaluating pharmacist
experiences in Qatar. Additionally, some CPs lacked confidence and the resources required to carry
out research. These observations were similar to those held by Daly [24], who described a project
where eight pharmacists were appointed as part time community pharmacy research facilitators to
establish a network of interested pharmacists who would contribute to research. She reported that
“many pharmacy teams assumed that . . . research was time consuming and onerous” [24]. CPs felt
that remuneration was the biggest incentive to facilitate research followed by training tools, protected
time, and support from management.
Lack of appropriate infrastructure to do research was listed as another barrier with CPs, suggesting
that management should put research on their agenda. They felt that appropriate infrastructure would
include guidance, training, and notification of research topics. The RPS hopes that with its Research
and Evaluation Hub, this will become a valuable resource for pharmacists hoping to learn the skills
required to become involved in research [14]. However, more awareness of such support is needed.
In regards to the role CPs wanted to play in research, the most commonly suggested role was recruiting
patients for research, as well as taking part in audits and service evaluations.
Of note, younger pharmacists appeared to be more interested in taking part in research than
their older counterparts. This could be due, in part, to their more recent experience of completing an
academic research project in their MPharm course. A study by Langley et al. [25] noted that almost
two-thirds (61%) of final year MPharm students considered their research project to be very important
or fairly important, a perception that may continue into their early career. Three pharmacists in the
interviews, however, felt that undergraduate pharmacy programmes needed to be even more focused
on research, hypothesising that if this was the case then future pharmacists’ skills could be built upon
from an early stage in their career and engagement in research would become the norm. Professor
Dean Franklin of the Modernising Pharmacy Careers Programme board states, “Research is like an
apprenticeship; you can only learn by doing it but, unless you have the opportunity to start doing it,
it’s very difficult to develop the necessary skills and expertise” [26].
The findings of this study add to the outcomes of similar studies [27,28] in countries other
than the UK and demonstrate an emerging trend for greater community pharmacist involvement in
research [23].
Limitations of this study include a low response rate, meaning broad generalisations could not be
made. Although random selection was used, selection bias may have occurred with the participation
of those more interested in research. The authors’ assumption that one pharmacist worked in each
pharmacy may be inaccurate for some pharmacies; this may mean that our sample is not representative
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of all pharmacist opinions. In addition, as this research was carried out in 2014, there is a possibility
that community pharmacists may feel differently about research following the launch of the new
Research and Evaluation Hub by the RPS.
5. Conclusions
Active involvement in pharmacy research has been acknowledged by community pharmacists in
this study as being important to the future of the profession. Practice research can help community
pharmacy to conform within the NHS reforms.
Many pharmacists would like to become more involved in research, but feel that factors like lack
of training and lack of employer support limit any research they could do. More training in research
techniques, as well as more promotion of pharmacy research priorities, would help to ensure that
more pharmacists contribute to essential research projects and showcase the profession as being at the
forefront of evidence-based practice.
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